Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

NCT03679767

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Fresno, California, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • California Cancer Associates for Research and Excellence, Inc. San Marcos, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
View all 52 locations
View Trial Details
Completed

A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

NCT02627963

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • University Of UA Cancer Center(UACC)/DH-SJHMC Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology - Phoenix - Deer Valley Women's Center Loca Phoenix, Arizona, United States
  • Arizona Oncology - Scottsdale Scottsdale, Arizona, United States
View all 191 locations
View Trial Details
Completed

Professional Bladder Cancers and the Profession of Painter

NCT05937555

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • CHRU de Brest Brest, France
  • CHU de Caen Caen, France
  • Ch Cherbourg Cherbourg, France
  • CH le Havre Le Havre, France
View Trial Details
Completed

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

NCT00068393

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
View all 92 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

NCT02579811

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions